Molina Healthcare stock holds near the 52-week low

Published on 09/20/2026 at 20:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Molina Healthcare stock closed at USD 201.22 on September 18, 2026, with a market value of USD 10.50 billion. MarketBeat shows a consensus target of USD 202.44.

Moderner Klinikcampus mit Glasfassade und Gesundheitspersonal vor Skyline — Fotorealistisches Bild zeigt Molina Healthcare US60855R1005 als modernen Klinikcampus mit Personal und Skyline im Hintergrund, Illustration mit AI erstellt.

Molina Healthcare stock (US60855R1005) closed at USD 201.22 on September 18, 2026, and finished the session with a market capitalization of USD 10.50 billion. The shares were down 1.89 percent on the day, while MarketBeat showed a consensus target of USD 202.44 and a 52-week range of USD 121.06 to USD 244.89.

Consensus is tight

According to MarketBeat, Molina Healthcare has 3 buy ratings, 12 hold ratings and 2 sell ratings, with an average rating of Hold on September 20, 2026. The same page puts the stock's average price target at USD 202.44, only 0.61 percent above the closing price from September 18, 2026.

That gap is small. For investors, the target cluster suggests the market is already discounting a lot of the near-term analyst view.

Trading near support

MarketBeat's snapshot also shows volume of 860,044 shares, above the listed average volume of 562,417 shares, and a trailing EPS of USD -0.18. The stock traded within a 52-week band that runs from USD 121.06 to USD 244.89, putting the latest close near the lower half of that range.

According to MarketBeat, Sanford C. Bernstein kept a USD 286.00 target on Molina Healthcare, while Truist Financial cut its target from USD 250.00 to USD 225.00 and held a Hold rating. The same item says the stock has 8 research reports in the past 90 days, a sign that analyst attention remains elevated.

Price stays contained

The last quoted price was USD 201.22 on September 18, 2026, with extended trading at USD 200.72 at 7:33 PM Eastern. The market is still pricing Molina Healthcare close to the consensus target, not far above the lower end of its yearly range.